Almac distribution network now worldwide

Clinical Services expands its global depot network across SE Asia

Almac Clinical Services have announced further additions to their global distribution depot network. The company has signed a new distributorship agreement with a major commercial Pharmaceutical distributor covering the South-East Asia region. The hub facility in Singapore covers IMP distribution across South-East Asia, including Malaysia, Taiwan, the Philippines, Korea and Thailand.

Also, further agreements are now operational in China and India, two key emerging markets within the clinical trials Industry. These agreements are another major boost to the range and breadth of service offered by Almac for global IMP distribution.

Logistics Manager Andrew Scott said:

“We are delighted to add these territories to our global depot network. These will enable us to offer our clients extensive coverage for any future trials that may be performed in these regions. We have effectively responded to the market need to offer GMP compliant distribution services within these key clinical trial countries, and have greatly improved our offering to prospective clients.”

Robert Dunlop, President and MD, Almac Clinical Services said:

“This move forms part of our overall strategy to provide a range of clinical trial services globally to our clients. The opening of emerging markets in the clinical trial industry requires companies with a global presence to ensure effective reach for shipping of patient supplies worldwide.”

These additions build on an existing depot network located across the world including Russia, Ukraine, Argentina, Mexico, Brazil, Peru, Chile, Israel, France and Australia.

-Ends-

Contact:

Jonathan Calderwood

Global Marketing Manager, Almac Clinical Services

+44(0)28 3836 2436

jonathan.[email protected]

Carl Whyte

Stakeholder Communications

+44 (0)28 9033 9949